Natasha Rafter Selected Research

Lipids

1/2017

The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Natasha Rafter Research Topics

Disease

8	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 10/2005
1	Heart Failure 12/2013
1	Coronary Disease (Coronary Heart Disease) 12/2013
1	Diabetes Mellitus 12/2013
1	Vascular Diseases (Vascular Disease) 04/2009
1	Communicable Diseases (Infectious Diseases) 12/2004

Drug/Important Bio-Agent (IBA)

4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 05/2014
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2011
4	CholesterolIBA 12/2013 - 02/2008
2	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 01/2016
1	LipidsIBA 01/2017
1	CreatinineIBA 12/2013
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2011
1	Lisinopril (Prinivil)FDA LinkGeneric 01/2011
1	Simvastatin (Zocor)FDA LinkGeneric 01/2011
1	VitaminsIBA 12/2004

Therapy/Procedure

3	Therapeutics 01/2019 - 10/2005